Joost J. van Veen

Guideline on the management of bleeding in patients on antithrombotic agents

Joost J. van Veen, Andrew Mumford · British Journal of Haematology · 2012 · 229 citations

Medicine, Hematology, Pharmacotherapy +17

Real-world experience with caplacizumab in the management of acute TTP

Tina Dutt, Rebecca Shaw, Matthew Stubbs et al. · Blood · 2020 · 159 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +2

Presenting ADAMTS13 antibody and antigen levels predict prognosis in immune-mediated thrombotic thrombocytopenic purpura

Ferras Alwan, Chiara Vendramin, Karen Vanhoorelbeke et al. · Blood · 2017 · 126 citations · Full text

Medicine, Hematology, Pathology +12

Protamine reversal of low molecular weight heparin

Joost J. van Veen, Rhona Maclean, K. K. Hampton et al. · Blood Coagulation & Fibrinolysis · 2011 · 102 citations

Medicine, Hematology, Pharmacotherapy +17

Corn trypsin inhibitor in fluorogenic thrombin-generation measurements is only necessary at low tissue factor concentrations and influences the relationship between factor VIII coagulant activity and thrombogram parameters

Joost J. van Veen, Alex Gatt, Peter Cooper et al. · Blood Coagulation & Fibrinolysis · 2008 · 99 citations

Medicine, Biochemistry, Hematology +17